Conformational Dependence and Conservation of an Immunodominant Epitope within the Babesia equi Erythrocyte-Stage Surface Protein Equi Merozoite Antigen 1
- 1 November 2002
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 9 (6) , 1301-6
- https://doi.org/10.1128/cdli.9.6.1301-1306.2002
Abstract
Equi merozoite antigen 1 (EMA-1) is an immunodominant Babesia equi erythrocyte-stage surface protein. A competitive enzyme-linked immunosorbent assay (ELISA), based on inhibition of monoclonal antibody (MAb) 36/133.97 binding to recombinant EMA-1 by equine anti- B. equi antibodies, detects horses infected with strains present throughout the world. The objectives of this study were to define the epitope bound by MAb 36/133.97 and quantify the amino acid conservation of EMA-1, including the region containing the epitope bound by MAb 36/133.97. The alignment of the deduced amino acid sequence of full-length EMA-1 (Florida isolate) with 15 EMA-1 sequences from geographically distinct isolates showed 82.8 to 99.6% identities (median, 98.5%) and 90.5 to 99.6% similarities (median, 98.9%) between sequences. Full-length and truncated recombinant EMA-1 proteins were expressed and tested for their reactivities with MAb 36/133.97. Binding required the presence of amino acids on both N- and C-terminal regions of a truncated peptide (EMA-1.2) containing amino acids 1 to 98 of EMA-1. This result indicated that the epitope defined by MAb 36/133.97 is dependent on conformation. Sera from persistently infected horses inhibited the binding of MAb 36/133.97 to EMA-1.2 in a competitive ELISA, indicating that equine antibodies which inhibit binding of MAb 36/133.97 also recognize epitopes in the same region (the first 98 residues). Within this region, the deduced amino acid sequences had 85.7 to 100% identities (median, 99.0%), with similarities of 94.9 to 100% (median, 100%). Therefore, the region which binds to both MAb 36/133.97 and inhibiting equine antibodies has a median amino acid identity of 99.0% and a similarity of 100%. These data provide a molecular basis for the use of both EMA-1 and MAb 36/133.97 for the detection of antibodies against B. equi .Keywords
This publication has 20 references indexed in Scilit:
- Detection of Antibodies to Babesia equi in Horses by a Latex Agglutination Test Using Recombinant EMA-1Clinical and Diagnostic Laboratory Immunology, 2001
- Validation of a Competitive Enzyme-Linked Immunosorbent Assay for Diagnosing Babesia Equi Infections of Moroccan Origin and Its Use in Determining the Seroprevalence of B. Equi in MoroccoJournal of Veterinary Diagnostic Investigation, 2001
- Expression of Babesia equi Merozoite Antigen 1 in Insect Cells by Recombinant Baculovirus and Evaluation of Its Diagnostic Potential in an Enzyme-Linked Immunosorbent AssayJournal of Clinical Microbiology, 2001
- Expression of Babesia equi merozoite antigen-2 by recombinant baculovirus and its use in the ELISA1Note: Nucleotide sequence data reported in this paper are available in the EMBL, GenBank™ and DDJB databases under the accession number AB013725.1International Journal for Parasitology, 1999
- An account on equine babesiosesRevue Scientifique et Technique de l'OIE, 1996
- A cellular form of prion protein (PrPC) exists in many non-neuronal tissues of sheepJournal of General Virology, 1995
- A Babesia equi gene encodes a surface protein with homology to Theileria speciesMolecular and Biochemical Parasitology, 1993
- Haemoparasites of equines : impact on international trade of horsesRevue Scientifique et Technique de l'OIE, 1990
- A simple method for displaying the hydropathic character of a proteinJournal of Molecular Biology, 1982
- EVALUATION OF AN INDIRECT FLUORESCENT ANTIBODY TEST TO DIAGNOSE BABESIA EQUI INFECTION IN HORSESAustralian Veterinary Journal, 1979